346 related articles for article (PubMed ID: 19826413)
1. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer.
Szajnik M; Szczepanski MJ; Czystowska M; Elishaev E; Mandapathil M; Nowak-Markwitz E; Spaczynski M; Whiteside TL
Oncogene; 2009 Dec; 28(49):4353-63. PubMed ID: 19826413
[TBL] [Abstract][Full Text] [Related]
2. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway.
Huang JM; Zhang GN; Shi Y; Zha X; Zhu Y; Wang MM; Lin Q; Wang W; Lu HY; Ma SQ; Cheng J; Deng BF
Sci Rep; 2014 Jan; 4():3840. PubMed ID: 24452475
[TBL] [Abstract][Full Text] [Related]
3. TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells.
Sun NK; Huang SL; Chang TC; Chao CC
J Cell Physiol; 2018 Mar; 233(3):2489-2501. PubMed ID: 28771725
[TBL] [Abstract][Full Text] [Related]
4. Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.
Chuffa LG; Fioruci-Fontanelli BA; Mendes LO; Ferreira Seiva FR; Martinez M; Fávaro WJ; Domeniconi RF; Pinheiro PF; Delazari Dos Santos L; Martinez FE
BMC Cancer; 2015 Feb; 15():34. PubMed ID: 25655081
[TBL] [Abstract][Full Text] [Related]
5. The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.
d'Adhemar CJ; Spillane CD; Gallagher MF; Bates M; Costello KM; Barry-O'Crowley J; Haley K; Kernan N; Murphy C; Smyth PC; O'Byrne K; Pennington S; Cooke AA; Ffrench B; Martin CM; O'Donnell D; Hennessy B; Stordal B; Finn S; McCann A; Gleeson N; D'Arcy T; Flood B; O'Neill LA; Sheils O; O'Toole S; O'Leary JJ
PLoS One; 2014; 9(6):e100816. PubMed ID: 24977712
[TBL] [Abstract][Full Text] [Related]
6. Anti-Inflammatory Activity of Adenosine 5'-Trisphosphate in Lipopolysaccharide-Stimulated Human Umbilical Vein Endothelial Cells Through Negative Regulation of Toll-Like Receptor MyD88 Signaling.
Luo X; Xiao B; Xiao Z
DNA Cell Biol; 2019 Dec; 38(12):1557-1563. PubMed ID: 31580158
[TBL] [Abstract][Full Text] [Related]
7. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis.
Sun Z; Luo Q; Ye D; Chen W; Chen F
Mol Cancer; 2012 May; 11():33. PubMed ID: 22583829
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.
Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W
Tumour Biol; 2016 Sep; 37(9):11883-11891. PubMed ID: 27059733
[TBL] [Abstract][Full Text] [Related]
9. Effect of Paclitaxel+Hirudin on the TLR4-MyD88 Signaling Pathway During Inflammatory Activation of Human Coronary Artery Smooth Muscle Cells and Mechanistic Analysis.
Li H; Wang X; Xu A
Cell Physiol Biochem; 2018; 50(4):1301-1317. PubMed ID: 30355931
[TBL] [Abstract][Full Text] [Related]
10. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
Gaikwad SM; Thakur B; Sakpal A; Singh RK; Ray P
Int J Biochem Cell Biol; 2015 Apr; 61():90-102. PubMed ID: 25681684
[TBL] [Abstract][Full Text] [Related]
11. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
12. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.
Szczepanski MJ; Czystowska M; Szajnik M; Harasymczuk M; Boyiadzis M; Kruk-Zagajewska A; Szyfter W; Zeromski J; Whiteside TL
Cancer Res; 2009 Apr; 69(7):3105-13. PubMed ID: 19318560
[TBL] [Abstract][Full Text] [Related]
13. Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
Liu H; Zhang G; Huang J; Ma S; Mi K; Cheng J; Zhu Y; Zha X; Huang W
J Transl Med; 2016 Apr; 14(1):104. PubMed ID: 27118139
[TBL] [Abstract][Full Text] [Related]
14. The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer.
Bates M; Spillane CD; Gallagher MF; McCann A; Martin C; Blackshields G; Keegan H; Gubbins L; Brooks R; Brooks D; Selemidis S; O'Toole S; O'Leary JJ
PLoS One; 2020; 15(12):e0243715. PubMed ID: 33370338
[TBL] [Abstract][Full Text] [Related]
15. Isoforskolin and forskolin attenuate lipopolysaccharide-induced inflammation through TLR4/MyD88/NF-κB cascades in human mononuclear leukocytes.
Du X; Shi R; Wang Y; Wu W; Sun S; Dai Z; Chen C; Weng Z; Li X; Liu Q; Zhang L; Saidian M; Yang W
Phytother Res; 2019 Mar; 33(3):602-609. PubMed ID: 30637903
[TBL] [Abstract][Full Text] [Related]
16. GEF-H1-RhoA signaling pathway mediates LPS-induced NF-κB transactivation and IL-8 synthesis in endothelial cells.
Guo F; Tang J; Zhou Z; Dou Y; Van Lonkhuyzen D; Gao C; Huan J
Mol Immunol; 2012 Feb; 50(1-2):98-107. PubMed ID: 22226472
[TBL] [Abstract][Full Text] [Related]
17. Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells.
Wang AC; Su QB; Wu FX; Zhang XL; Liu PS
Eur J Clin Invest; 2009 Feb; 39(2):157-64. PubMed ID: 19200169
[TBL] [Abstract][Full Text] [Related]
18. The regulatory effect of oxymatrine on the TLR4/MyD88/NF-κB signaling pathway in lipopolysaccharide-induced MS1 cells.
Lu M; Zhang Q; Chen K; Xu W; Xiang X; Xia S
Phytomedicine; 2017 Dec; 36():153-159. PubMed ID: 29157809
[TBL] [Abstract][Full Text] [Related]
19. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
20. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]